Massachusetts

  • September 16, 2026

    Contractor, Defense Agency Reach Ch. 11 Claim Setoff Deal

    Bankrupt government defense contractor Noble Supply & Logistics LLC reached a short-term deal with the Defense Logistics Agency on Wednesday in Delaware court that will allow for the agency to make contractual payments to the debtor as it pursues a Chapter 11 asset sale.

  • September 16, 2026

    1st Circ. Hints Trump Admin Sought To Skirt Review Of Cuts

    The First Circuit on Wednesday repeatedly suggested that the Trump administration had sought to evade court review by intentionally failing to issue written guidance before it began shuttering federal programs targeted by the president in an executive order last year.

  • September 16, 2026

    Muscular Dystrophy Drug Co. Beats Investor Suit Over Risks

    A Massachusetts federal judge denied investors another chance to rework their suit accusing Sarepta Therapeutics and its executives of misleading the market about the safety and efficacy of their muscular dystrophy treatments, saying it fails to show they knew about issues with the products and trials when they made certain statements.

  • September 16, 2026

    States Say DOJ's RealPage Deal Doesn't Affect Their Claims

    A group of states told a North Carolina federal court to reject property management software company RealPage Inc.'s argument that its rent price-fixing settlement with the federal government moots the states' antitrust claims.

  • September 16, 2026

    1st Circ. Judge 'Roe' Denies $1B Lotto Winner's Secrecy Bid

    A man who won more than $1 billion in a lottery cannot keep his identity secret in a lawsuit over a nondisclosure agreement, a panel of the First Circuit has ruled, with the judge who authored the decision using a pseudonym to prove a point before disclosing her name in a footnote. 

  • September 16, 2026

    EOFlow Says Fed. Circ. Right To Ax $59M Trade Secret Verdict

    EOFlow Co. Ltd. says the Federal Circuit shouldn't rethink a panel's decision allowing it to escape a $59.4 million trade secret judgment, saying insulin product developer Insulet Corp. is trying to dress up factual disputes as issues needing the full court's attention.

  • September 16, 2026

    Conn. Judge Trims Claims In 3M Firefighter PFAS Suit

    A Connecticut federal judge has dismissed some "forever chemicals" allegations lodged against 3M Co. by state firefighter unions and firefighters in a Minnesota multidistrict litigation concerning municipalities that purchased firefighting turnout gear, ruling that the unions lack associational standing over certain claims in the case.

  • September 15, 2026

    DOJ Says States Could Owe Bond In Paramount Merger Case

    The U.S. Department of Justice said Tuesday that a coalition of state attorneys general and the Writers Guild of America could indeed be required to put up a bond as they challenge Paramount's acquisition of Warner Bros. Discovery, but only if the order they secured truly constitutes an injunction.

  • September 15, 2026

    How States' 'Perry Mason Moment' Led To $17B Meta Deal

    A recent landmark $17.1 billion settlement with Meta Platforms Inc. may have never happened if it weren't for a quick-thinking trial attorney and his close-knit team of lawyers representing 29 states, who worked together to swiftly shift strategies midtrial.

  • September 15, 2026

    States Say DOJ Trans Care Crackdown Is Unconstitutional

    States suing the Trump administration have urged a Massachusetts federal judge to strike down directives calling for providers of gender-affirming care to be investigated and prosecuted by the U.S. Department of Justice, arguing the directives are arbitrary and capricious and violate the Tenth Amendment.

  • September 15, 2026

    Meet The Attys In The 340B Battle At 1st Circ.

    Gibson Dunn and Dunn Isaacson Rhee attorneys presented arguments Tuesday at the First Circuit over whether drug manufacturers can intervene in a challenge to a now-suspended drug rebate program for hospitals. Law360 profiles the attorneys.

  • September 15, 2026

    Takeda Can't Decertify Amitiza Class After $885M Jury Loss

    A Massachusetts federal court refused Takeda's request to decertify a class of Amitiza buyers, after a jury awarded groups of purchasers a total of $885 million for claims that the drugmaker conspired to delay the launch of a rival generic version of the anti-constipation drug.

  • September 15, 2026

    1st Circ. Suggests Appeal In Drug Rebate Case May Be Moot

    A First Circuit panel raised mootness concerns as it heard arguments Tuesday from drug companies appealing a ruling that prevented them from intervening in a now-dismissed case to defend a rebate model for a federal drug-pricing program. 

  • September 15, 2026

    1st Circ. Presses Amex On Merchant Arbitration Rule Change

    A First Circuit panel on Tuesday pushed back on assertions by American Express that unilateral changes to the terms of its merchant agreement did not invalidate it, as a lower court found last year in denying the card issuer's motion to compel arbitration in a dispute over anti-steering rules.

  • September 15, 2026

    Judge Halts 'Catastrophic' Fixed-Term Student Visa Rule

    A Massachusetts federal judge Monday blocked a Trump administration rule that would have imposed restrictions on foreign student visas, finding that the federal government's purported justification for the sweeping new rules is weak and "borders on the absurd."

  • September 14, 2026

    Crypto Bill Faces Wide Criticism Ahead Of Initial Vote

    Senate Republicans on Monday faced obstacles to securing support for their final draft of the Clarity Act ahead of a Tuesday procedural vote to move the crypto bill forward, as Democrats, banking organizations, state law enforcers and even some crypto interests criticized the new version of the legislation as coming up short in key areas.

  • September 14, 2026

    Paramount Says Warner Bros. Deal Is Good For Competition

    Paramount has told a California federal court its planned $110 billion acquisition of Warner Bros. Discovery will be good for competition, arguing that challenges of the deal from state enforcers and the Writers Guild of America are misguided.

  • September 14, 2026

    Supreme Court Blocks USPS Mail Ballot Rules For Midterms

    The U.S. Postal Service cannot enforce new mail-in ballot regulations ahead of this year's midterm elections, the U.S. Supreme Court ruled Monday, agreeing with an earlier First Circuit order that maintained a prohibition on the purported election integrity measures taking effect.

  • September 14, 2026

    21 States Seek To Halt Corteva's $39B PFAS Liability Spinoff

    The attorney general of California and 20 other states asked the South Carolina federal court managing multidistrict litigation over forever chemicals on Monday to stop Corteva Inc. from spinning off $39 billion in assets into a new company called Vylor Inc. to avoid liabilities from contamination over the substances.

  • September 14, 2026

    Jushi Opposes Pot Shop's Summary Bid On Antitrust Claims

    Cannabis giant Jushi Holdings and others are asking a federal court to toss a lawsuit alleging they made a $10 million deal to keep a rival out of town, arguing they did not participate in anticompetitive behavior and that the small, underfunded shop was never going to open regardless of anything they did.

  • September 14, 2026

    Ex-Perrigo VP Escapes Some Price-Fixing Claims From AGs

    A Connecticut federal judge has tossed most of the claims against a former Perrigo executive in sprawling generic-drug price-fixing litigation brought by state enforcers, holding there is insufficient evidence he entered into antitrust conspiracies related to more than a dozen dermatological drugs, but teeing up a handful of other claims for trial.

  • September 14, 2026

    NY-Led States, Cities Sue Over Trump Public Charge Rule

    A coalition of Democratic-led states and local governments sued the Trump administration on Monday, alleging that its revamped criteria for determining who is likely to become a public charge is arbitrary, will have a chilling effect and could worsen public health outcomes.

  • September 14, 2026

    Debt Buyer Settles Mass. AG Complaint Over Collection Tactics

    The owner of a Massachusetts debt buyer and collection agency has agreed to walk away from approximately $52 million he sought to collect through aggressive and allegedly illegal tactics, including seizing vehicles as a way to coerce payments on unrelated loans, the state attorney general's office said Monday.

  • September 14, 2026

    1st Circ. Says Hearst Info Sharing May Not Trigger VPPA

    The First Circuit appeared likely on Monday to affirm a lower court's finding that Hearst Television Inc.'s news and weather apps are not violating a 1980s-era video privacy law by disclosing users' email and geolocation data to marketing partners, suggesting that's not enough information to link individuals to specific viewed material.

  • September 14, 2026

    Foley Hoag Grows Debt Finance Team With New Co-Chair

    An attorney who built her debt finance practice for more than 26 years at Goodwin Procter LLP has recently joined Foley Hoag LLP's Boston office, where she has been selected to co-lead the firm's debt finance team.

Expert Analysis

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • Mass. UHC Fraud Suit Signals States' Medicaid FCA Push

    Author Photo

    Massachusetts' recently filed False Claims Act suit alleging UnitedHealthcare misrepresented the health status of enrollees in a Medicaid senior care organization plan it managed pushes forward a new phase of state-level scrutiny of managed care data and Medicaid payment mechanisms, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwendolyn Stamper at Vogel Slade.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • Solar's Momentum At Mid-2026 Will Help It Overcome Snags

    Author Photo

    The rapid expansion of U.S. solar development in the first half of 2026 is likely to continue its pace, even amid ongoing shifts in federal trade policy and supply chain regulations, obstacles to permitting reform, and an increasing divide between states enacting policies to encourage or stymie project development, say attorneys at Beveridge & Diamond.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • How Pfizer Won Fed. Circ. Patent Dispute By 1 Carbon Atom

    Author Photo

    The Federal Circuit's recent refusal to revive a patent in Enanta Pharmaceuticals v. Pfizer over an alleged typo creating a one-atom difference in a COVID-19 treatment application hands defendants a template for potentially converting a triable fact question into an early dispositive ruling, say attorneys at Polsinelli.

  • Laptop Farms Highlight Identity Fraud Risks Of Remote Work

    Author Photo

    Two U.S. nationals' recent sentencing in Massachusetts federal court for a scheme that enabled foreign operatives to obtain remote jobs at U.S. companies using stolen identities is a reminder that employers must recalibrate their remote hiring, onboarding and monitoring practices to mitigate evolving cybersecurity and geopolitical risks, say attorneys at Foley & Lardner.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Immigration Ruling Maps Alternative To Universal Injunctions

    Author Photo

    A Rhode Island federal court's decision in Dorcas International Institute of Rhode Island v. USCIS vacating policies that froze key immigration adjudications for nationals of 39 countries, and paused asylum applications altogether, suggests how practitioners might press for the Administrative Procedure Act's bad faith exception to record review and seek vacatur as a viable alternative to universal injunctions, says Kemal Hepsen at Mandamus Lawyers.

  • Series

    Choral Singing Makes Me A Better Lawyer

    Author Photo

    Singing in the New York City Bar Chorus — a hobby partly inspired by the late U.S. District Judge Richard Owen, who infused my clerkship year with opera music — has improved my legal career by refining my abilities to listen, exude confidence and develop emotional intelligence, says Bonnie Baker at Friedman Kaplan.

  • Attorney Mental Health Is An Ethical Obligation In The AI Era

    Author Photo

    As attorneys cope with the increasing unpredictability that artificial intelligence and constant policy changes have created, particularly in practice areas where they carry the emotional weight of clients’ most consequential life events, otherwise soft discussions about self-care are a matter of professional competence, says attorney Jack Jrada.

  • Key Tips For Patenting Antibody-Drug Conjugate Inventions

    Author Photo

    Recent decisions highlight the significant challenges that can arise when patenting antibody-drug conjugates, which require strategic considerations for satisfying heightened written description and enablement requirements, says Xiaoban Xin at FisherBroyles.

  • $885M IBS Drug Verdict Tests Pay-For-Delay Limits

    Author Photo

    The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement reverse payment since the U.S. Supreme Court adopted the rule-of-reason legal framework in 2013, offering a blueprint for pay-for-delay claims, say attorneys at Katten.

  • Series

    Power To The Paralegals: Burnout As A Structural Problem

    Author Photo

    Law firm leadership can best retain their paralegals not by encouraging self-care, but by seeking top-down structural solutions for the quiet proliferation of responsibilities and the vicarious exposure to client trauma that particularly drive burnout in this vital role, says Erika Sneeringer at Brockstedt Mandalas.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Massachusetts archive.